CDC’s Division of Select Agents and Toxins (DSAT)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NIAID
|
The workgroup held biweekly meetings to discuss the following: point of regulation of select toxins (Botulinum neurotoxins, Staphylococcal enterotoxins, Abrin, Ricin, Conotoxins, Saxitoxin, Tetrodotoxin, Diacetoxyscirpenol, T-2 toxin), natural environment, toxin exclusion limits, space decontamination, and potential updates to the CDC’s manual “Biosafety in Microbiological and Biomedical Laboratories.”
|
CDC’s Field Epidemiology Training Program (FELP) Cancer Curriculum
|
Training Initiative
|
CDC
|
NCI
|
CDC and NCI (Center for Global Health and Cancer Prevention Fellowship Program) are collaborating to add a cancer curriculum to CDC’s Field Epidemiology Training Program.
|
Center for Disease Control (CDC) and Health Resources and Services Administration (HRSA) Advisory Committee on HIV, Viral Hepatitis, and STD Prevention and Treatment (CHACHSPT)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
OD/DPCPSI/OAR
|
The CDC / HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment shall advise the Secretary; the Director, CDC; and the Administrator and Associate Administrator for HIV/AIDS, and HRSA, regarding objectives, strategies, policies, and priorities for HIV and STD/hepatitis prevention and treatment efforts including surveillance of HIV infection, AIDS, STDs/hepatitis, and related behaviors; epidemiologic, behavioral, health services, and laboratory research on HIV/AIDS and STDs/hepatitis; identification of policy issues related to HIV/STD/hepatitis professional education, patient healthcare delivery, and prevention services; agency policies about prevention of HIV/AIDS and other STDs, treatment, healthcare delivery, and research and training; strategic issues influencing the ability of CDC and HRSA to fulfill their missions of providing prevention and treatment services; programmatic efforts to prevent and treat HIV and STDs/hepatitis; and support to the agencies in their development of responses to emerging health needs related to HIV and other STDs/hepatitis.
|
Centers for Medicare and Medicare Services (CMS)- NIH Data Access Committee
|
Committee, Work group, Advisory group, or Task Force
|
CMS
|
NINR, CC, CSR, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIMH, NIMHD, NINDS, NLM, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP, OD/OSP
|
Observational studies based, in part, on available Centers for Medical and Medicare Services (CMS) data could generate important knowledge and policy relevant findings. NIH and CMS established a Data Access Committee to identify and pursue short and long term research priorities. Current initiatives include: implementation of an Inter-Agency Agreement wherein NIH directly purchases blanket access to CMS data from CMS, instead of paying grantees to access these data individually (which incurs high indirect cost rates for NIH); and convening quarterly meetings of the CMS-NIH Data Access Committee to discuss data policy and access issues. Future meetings may include presentations by NIH-funded investigators and in-house CMS data analyses.
|
Characterizations of Fungal Exposures
|
Research Initiative
|
CDC
|
NIEHS
|
These studies address the limitations in traditional methods for assessing fungal exposures by using molecular techniques to identify fungi in dust samples and biological fluids.
|
Characterize Emerging HIV Strains from Blood Donors and Patients
|
Resource Development
|
FDA
|
NIAID
|
This initiative will characterize emerging HIV strains from blood donors and patients to determine viral tropism based on co-receptor usage strains. It will update the global viral panels to analyze multiple, diverse isolates from different parts of the world. This activity is part of NIAID’s ongoing efforts to develop a well-characterized repository for diagnostics, and drug and vaccine studies.
|
Chemical Integrated Program Team (IPT)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
NICHD
|
This workgroup is a Public Health Energy Enterprise. The Chemical Integrated Program Team (IPT) working group provides an end-to-end vision of medical countermeasures needed for a particular threat type (e.g., anthrax, radiation/nuclear, etc.). The scope of their work includes setting requirements for the stockpiling of Medical Countermeasures (MCMs), MCM delivery, and dispensing and monitoring MCM development. The IPTs also advise the Enterprise Executive Committee as to threat- or capability-specific MCM priorities for improving preparedness, to inform leadership consideration of cross-threat prioritizations and strategic goal setting.
|
Chemical, Biologic, Radiologic, Nuclear and Explosive (CBRNE) Branch Subject Matter Advisory Resource Team (SMART)
|
Committee, Work group, Advisory group, or Task Force
|
OS
|
NICHD
|
The Subject Matter Advisory Resource Team (SMART) works to conduct analysis of response issues or problems in an unencumbered, academic environment to triage potential issues out or provide decision support when indicated. Participation is generally limited to facilitate rapid analysis and fluid discussion. Depending on the natural of any incident (e.g. Chem, Bio, Nuke/Rad, etc.), this list will be augmented and subject specific participants may be added or subtracted.
|
CHEMM (Chemical Hazards Emergency Medical Management)
|
Resource Development
|
ATSDR, CDC, OS
|
NLM
|
This activity is to develop and maintain a comprehensive web resource and mobile app (in conjunction with the Wireless Information System for Emergency Responders [WISER]). Chemical Hazards Emergency Medical Management (CHEMM) is a tool designed to provide access to comprehensive sets of information about chemical hazards via a user-friendly interface.
|
Chronic Fatigue Syndrome Advisory Committee (CFSAC)
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, FDA, HRSA, OS
|
NINDS, CSR, NCATS, NCCIH, NCI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDCR, NIDDK, NIEHS, NIMH, NINR, NLM, OD/DPCPSI/OBSSR
|
The Chronic Fatigue Syndrome Advisory Committee (CFSAC) provides advice and recommendations to the Secretary of Health and Human Services via the Assistant Secretary for Health of the U.S. Department of Health and Human Services on issues related to myalgic encephalomyelitis and chronic fatigue syndrome (ME/CFS). These include: 1) factors affecting access and care for persons with ME/CFS; 2) the science and definition of ME/CFS; and 3) broader public health, clinical, research and educational issues related to ME/CFS.
|